propranolol has been researched along with Neoplasms, Vascular in 14 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Infantile hemangiomas which have numerous similarities with chorioangiomas are now usually treated with propranolol." | 7.81 | Propranolol during pregnancy for large chorioangioma. ( D'Hervé, D; Fouque, L; Le Duff, M; Padys, P; Poulain, P, 2015) |
| "Kaposiform hemangioendothelioma is a rare vascular tumor in children." | 5.37 | Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment. ( de Blaauw, I; Hermans, DJ; Kool, LJ; van Beynum, IM; van der Vijver, RJ; van der Vleuten, CJ, 2011) |
| "Serum GLUT1, IGF-2, and VEGF-A levels were positively correlated with disease severity in patients with hemangioma, for example, in complicated hemangioma and hemangioma requiring propranolol treatment." | 4.02 | Evaluation of GLUT1, IGF-2, VEGF, FGF 1, and angiopoietin 2 in infantile hemangioma. ( Aydin Köker, S; Köker, A; Köksoy, AY; Kömüroğlu, AU; Şiraz, ÜG; Tekin, E, 2021) |
| " Infantile hemangiomas which have numerous similarities with chorioangiomas are now usually treated with propranolol." | 3.81 | Propranolol during pregnancy for large chorioangioma. ( D'Hervé, D; Fouque, L; Le Duff, M; Padys, P; Poulain, P, 2015) |
| "Propranolol has revolutionized the treatment of infantile hemangiomas, and other beta-blockers provide promising alternatives." | 2.52 | Beta-blockers for childhood vascular tumors. ( Bayart, CB; Brandling-Bennett, HA, 2015) |
| "Kaposiform hemangioendothelioma is a rare vascular tumor in children." | 1.37 | Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment. ( de Blaauw, I; Hermans, DJ; Kool, LJ; van Beynum, IM; van der Vijver, RJ; van der Vleuten, CJ, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Höger, PH | 1 |
| Hamm, H | 1 |
| Volonté, M | 1 |
| Codazzi, AC | 1 |
| Davidovich, S | 1 |
| Apicella, A | 1 |
| Isoletta, E | 1 |
| Barruscotti, S | 1 |
| Massa, M | 1 |
| Silvestri, A | 1 |
| Marseglia, GL | 1 |
| Brazzelli, V | 1 |
| Aydin Köker, S | 1 |
| Kömüroğlu, AU | 1 |
| Köksoy, AY | 1 |
| Şiraz, ÜG | 1 |
| Tekin, E | 1 |
| Köker, A | 1 |
| Ozyörük, D | 1 |
| Zengin, E | 1 |
| Boucek, RJ | 2 |
| Kirsh, AL | 1 |
| Majesky, MW | 1 |
| Perkins, JA | 1 |
| Hoeger, PH | 1 |
| Harper, JI | 1 |
| Baselga, E | 2 |
| Bonnet, D | 1 |
| Boon, LM | 1 |
| Ciofi Degli Atti, M | 1 |
| El Hachem, M | 1 |
| Oranje, AP | 1 |
| Rubin, AT | 1 |
| Weibel, L | 1 |
| Léauté-Labrèze, C | 1 |
| Bayart, CB | 1 |
| Brandling-Bennett, HA | 1 |
| Padys, P | 1 |
| Fouque, L | 1 |
| Le Duff, M | 1 |
| D'Hervé, D | 1 |
| Poulain, P | 1 |
| Sidbury, R | 2 |
| Pastore, S | 1 |
| Londero, M | 1 |
| Cont, G | 1 |
| Di Leo, G | 1 |
| Ventura, A | 1 |
| Hermans, DJ | 1 |
| van Beynum, IM | 1 |
| van der Vijver, RJ | 1 |
| Kool, LJ | 1 |
| de Blaauw, I | 1 |
| van der Vleuten, CJ | 1 |
| Hochman, M | 1 |
| Drolet, BA | 1 |
| Frommelt, PC | 1 |
| Chamlin, SL | 1 |
| Haggstrom, A | 1 |
| Bauman, NM | 1 |
| Chiu, YE | 1 |
| Chun, RH | 1 |
| Garzon, MC | 1 |
| Holland, KE | 1 |
| Liberman, L | 1 |
| MacLellan-Tobert, S | 1 |
| Mancini, AJ | 1 |
| Metry, D | 1 |
| Puttgen, KB | 1 |
| Seefeldt, M | 1 |
| Ward, KM | 1 |
| Blei, F | 1 |
| Cassidy, L | 1 |
| Darrow, DH | 1 |
| Joachim, S | 1 |
| Kwon, EK | 1 |
| Martin, K | 1 |
| Perkins, J | 1 |
| Siegel, DH | 1 |
| Frieden, IJ | 1 |
| Condat, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Influence of Systemic Propranolol Treatment on the Physical Development of Paediatric Patients With Infantile Hemangiomas[NCT04651049] | 128 participants (Actual) | Observational | 2010-07-15 | Completed | |||
| Propanolol for Primary Prophylaxis for Variceal Bleed in Biliary Atresia - An Open Label Randomized Controlled Study[NCT04494763] | 92 participants (Anticipated) | Interventional | 2020-08-15 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for propranolol and Neoplasms, Vascular
| Article | Year |
|---|---|
[Infantile hemangioma : Clinical manifestation, treatment, and differential diagnoses].
Topics: Child; Diagnosis, Differential; Hemangioma; Hemangioma, Capillary; Humans; Neoplasms, Vascular Tissu | 2023 |
Treatment of infantile haemangiomas: recommendations of a European expert group.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aortic Coarctation; Cryotherapy; Diagnosis, Di | 2015 |
Beta-blockers for childhood vascular tumors.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Atenolol; Child, Prescho | 2015 |
Update on vascular tumors of infancy.
Topics: Cell Proliferation; Endothelium, Vascular; Humans; Infant; Neoplasm Staging; Prevalence; Propranolol | 2010 |
Management of vascular tumors.
Topics: Adrenergic beta-Antagonists; Child; Granuloma, Pyogenic; Hemangioendothelioma; Hemangioma; Humans; K | 2012 |
Initiation and use of propranolol for infantile hemangioma: report of a consensus conference.
Topics: Consensus Development Conferences as Topic; Hemangioma; Humans; Infant; Propranolol; Research Report | 2013 |
8 other studies available for propranolol and Neoplasms, Vascular
| Article | Year |
|---|---|
Propranolol for the treatment of infantile hemangiomas: a nine-year monocentric experience from a tertiary hospital.
Topics: Hemangioma, Capillary; Humans; Infant; Infant, Newborn; Propranolol; Tertiary Care Centers; Vascular | 2023 |
Evaluation of GLUT1, IGF-2, VEGF, FGF 1, and angiopoietin 2 in infantile hemangioma.
Topics: Angiopoietin-2; Biomarkers; Child; Child, Preschool; Cross-Sectional Studies; Enzyme-Linked Immunoso | 2021 |
Propranolol treatment of complicated hemangiomas.
Topics: Adrenergic beta-Antagonists; Female; Hemangioma, Capillary; Humans; Infant; Infant, Newborn; Male; P | 2014 |
Propranolol responsiveness in vascular tumors is not determined by qualitative differences in adrenergic receptors.
Topics: Adrenergic beta-Antagonists; Child, Preschool; Cross-Sectional Studies; Dose-Response Relationship, | 2013 |
Propranolol during pregnancy for large chorioangioma.
Topics: Adult; Female; Hemangioma; Humans; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome | 2015 |
Refractory iron-deficiency anaemia in a child with portal cavernoma.
Topics: Anemia, Iron-Deficiency; Antihypertensive Agents; Child; Hemangioma, Cavernous; Humans; Hypertension | 2011 |
Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment.
Topics: Adrenergic beta-Antagonists; Antineoplastic Agents, Phytogenic; Disseminated Intravascular Coagulati | 2011 |
[Jaundice and portal cavernoma].
Topics: Antineoplastic Agents; Cholestasis, Extrahepatic; Cohort Studies; Diagnosis, Differential; Follow-Up | 2006 |